5 Stocks to Buy According to GuardCap Asset Management

3. UnitedHealth Group Incorporated (NYSE:UNH)

GuardCap Asset Management’s Stake Value: $754,533,000
Percentage of GuardCap Asset Management’s 13F Portfolio: 9.88%
Number of Hedge Fund Holders: 103

UnitedHealth Group Incorporated (NYSE:UNH) is a health insurance company located in Minneapolis that provides health benefit plans and services to private and public sector organizations and individuals, as well as Medicare programs and prescription drug coverage.

GuardCap Asset Management increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3% in the first quarter, thereby consisting of 1.48 million shares valued at $754.53 million. Eagle Capital Management is a prominent shareholder of UnitedHealth Group Incorporated (NYSE:UNH), with 2.90 million shares worth more than $1.48 billion.

As part of a comprehensive research note on U.S. Healthcare Services, Bernstein analyst Lance Wilkes downgraded UnitedHealth Group Incorporated (NYSE:UNH) on May 26 from Outperform to Market Perform with a price objective of $561, down from $566. Even though UnitedHealth is the largest federal MCO and supplier of value-based care, Wilkes claimed that his new rating reflected the stock’s strong performance and rising relative earnings multiple.

The number of hedge funds tracked by Insider Monkey having stakes in UnitedHealth Group Incorporated (NYSE:UNH) grew to 103 in Q1, from 96 in the preceding quarter. These stakes hold a consolidated value of $12.82 billion, down from $13.67 billion.

In its Q1 2022 investor letter, Baron Funds mentioned UnitedHealth Group Incorporated (NYSE:UNH). Here is what the firm said:

“UnitedHealth Group Incorporated (NYSE:UNH) is a leading diversified health and wellbeing company whose divisions include insurance arm, United Healthcare and healthcare services arm, Optum, which offers care delivery and other services. Shares increased 1.8% on good fourth quarter results with revenues up 12.5% year-over-year, operating margins of 7.5% and EPS up 78% while also reaffirming its 2022 guidance. We believe UnitedHealth leads the health care industry in innovation and execution as evidenced by its strong value proposition leading to Medicare Advantage share gains, strong cost controls, and its leadership position in the shift to value-based care.”